Home/Filings/4/0001214659-18-000187
4//SEC Filing

Huang Kelly 4

Accession 0001214659-18-000187

CIK 0001427570other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 4:12 PM ET

Size

6.1 KB

Accession

0001214659-18-000187

Insider Transaction Report

Form 4
Period: 2018-01-02
Huang Kelly
Chief Operating Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-01-02+80,00080,000 total
    Exercise: $7.15Exp: 2028-01-02Common Stock (80,000 underlying)
Footnotes (1)
  • [F1]The Option shall vest as to 1/6th of the Shares underlying the Option on September 6, 2018 (i.e., the one-year anniversary of Mr. Huang's employment commencement date) and as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date thereafter, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date. In addition, any portion of the Option that vests prior to the date on which Mr. Huang relocates his primary residence in accordance with the Relocation Obligations (as defined in his employee offer letter agreement with the Company dated September 6, 2017) will not be exercisable until such relocation date. The Option will automatically expire if Mr. Huang does not satisfy the Relocation Obligations.

Issuer

OBALON THERAPEUTICS INC

CIK 0001427570

Entity typeother

Related Parties

1
  • filerCIK 0001602803

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:12 PM ET
Size
6.1 KB